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Abstract Sodium dodecyl sulphate (SDS), a detergent that
mimics some characteristics of biological membranes, has been
found to a¡ect signi¢cantly ¢bril formation by a peptide from
human complement receptor 1. In aqueous solution the peptide
is unfolded but slowly aggregates to form ¢brils. In sub-micellar
concentrations of SDS the peptide is initially K-helical but con-
verts rapidly to a L-sheet structure and large quantities of ¢brils
form. In SDS above the critical micellar concentration the pep-
tide adopts a stable K-helical structure and no ¢brils are observed.
These ¢ndings demonstrate the sensitivity of ¢bril formation to
solution conditions and suggest a possible role for membrane
components in amyloid ¢bril formation in living systems.
$ 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Amyloid ¢bril formation is associated with a wide range of
human debilitating disorders such as Alzheimer’s and Creutz-
feldt^Jakob diseases, senile systemic amyloidosis and type II
diabetes [1^5]. Initially it was generally believed that only a
small group of proteins could form the highly ordered ¢brillar
aggregates associated with these diseases. It has recently been
shown, however, that the ability to form ¢brils in vitro is not
limited to the 20 or so disease-associated proteins [5^10]. In-
deed, it has been suggested that the ability to form this type of
structure may be intrinsic to the polypeptide backbone, and a
generic property of polypeptide chains, although the propen-
sities of di¡erent sequences to form such species can di¡er
widely [7,9].
The conversion of globular proteins into ¢brils usually in-
volves major structural transitions leading to the partial or
complete disruption of the native fold under conditions in
which non-covalent interactions, such as hydrogen bonding,
remain favourable [7]. Aggregation of this type, therefore,
generally occurs under partially denaturing conditions or on
fragmentation of the polypeptide chain into segments that
cannot form the cooperative native structure of the protein.
K-Helical to L-sheet transitions play an essential role in the
process of ¢bril formation if the native form of the protein is
largely helical, as for example in the case of the prion protein,
as the aggregated amyloid structures are rich in L-sheet
[11,12]. Indeed it has been shown that stabilising K-helical
conformers in a denatured or non-globular ensemble relative
to more extended L-structures can reduce substantially the
propensity for aggregation and amyloid formation [13,14].
In order to explore the role of K to L transitions in ¢bril
formation in more detail we have examined the e¡ects of the
detergent sodium dodecyl sulphate (SDS) on the solution con-
formation and the propensity to form ¢brils of a peptide. SDS
above its critical micellar concentration (cmc) is known to
stabilise peptides in helical conformations [15,16], while below
its cmc SDS has been found to stabilise L-strands [17,18]. It
therefore provides an opportunity to alter the relative stability
of di¡erent conformations of a peptide simply by changing the
SDS concentration. Moreover, SDS mimics some properties
of lipid membranes and enables us to speculate on the possi-
ble role of the lipid components of membranes or the mem-
brane environment on the potential to form amyloid ¢brils.
The peptide studied in the present work is SCR3(18^34), a
17 residue fragment corresponding to residues 18^34 of the
SRC3 (short consensus repeat 3) domain from the human
complement receptor CR1 [19]. This receptor binds two active
complement proteins, C3b and C4b, and these interactions
form part of the catabolic and regulatory pathways of the
immune system. The 18^34 sequence spans a region in
SCR3/10 of CR1 at which both proteins have been reported
to bind [20]. The peptide was chosen for the present study
because it was found to form spontaneously very well-de¢ned
amyloid ¢brils under conditions that are readily studied ex-
perimentally.
2. Materials and methods
The peptide used here (STNRENFHYGSVVTYRS) was synthe-
sised by solid-phase methodology. The identity and purity of the ¢nal
product was con¢rmed by mass spectrometry (experimental mass
2016.1, calculated mass 2014.9) and reversed-phase high performance
liquid chromatography. SDS was purchased from Sigma (St. Louis,
MO, USA).
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Circular dichroism (CD) measurements were carried out on a Jasco
J720 Spectropolarimeter at 25‡C, using a Haake F8 temperature con-
troller. Far UV CD spectra were acquired using a cell of 1 mm path
length at 0.5 nm intervals over the wavelength range 190^250 nm. The
concentration of the peptide was determined by the UV absorption at
274 nm of the single tyrosine residue (O274 = 1420 M31 cm31). Solu-
tions of the peptide were prepared by dissolving lyophilised peptide in
deionised water, and the pH adjusted to 4.0 with small aliquots of
NaOH and HCl, or by adding the lyophilised peptide to solutions of
SDS in water at pH 4. The ¢nal concentration of peptide in aqueous
solution was set to 50 WM and the SDS concentrations to 3 mM or
20 mM.
For the electron microscopy (EM) studies aliquots of solutions
collected at di¡erent times during ¢bril formation were applied to
Formvar-coated grids, negatively stained with a solution of 2%
(w/v) uranyl acetate in water. The grids were washed, air-dried, and
then examined in a JEOL JEM1010 transmission electron microscope
operating at an accelerating voltage of 80 kV.
3. Results
3.1. Formation of ¢brils by SCR3(18^34) in aqueous solution
SCR3(18^34) adopts a predominantly random coil confor-
mation when initially dissolved in aqueous solution at pH 4
and 25‡C. This is illustrated by the CD spectrum of the pep-
tide in Fig. 1A in which a single minimum can be observed at
198 nm. A shoulder at 215 nm and a band at 227 nm are,
however, also observed in the spectrum and can be attributed
to the presence of a small proportion of turns or more ex-
tended regions of L-sheet structure in the conformational en-
semble. After two days of incubation at room temperature,
however, signi¢cant changes were observed in the intensity of
the CD spectrum (Fig. 1A). The spectrum is still characteristic
of a peptide in the random coil conformation, with a single
minimum at ca. 195 nm, suggesting that no signi¢cant struc-
tural changes have occurred in the peptide giving rise to the
CD spectrum. However, over that time period, the intensity of
the bands in the spectrum has decreased by a factor of at least
two. Electron micrographs of the sample reveal the presence
of a small number of well-de¢ned ¢brils (Fig. 1B). The ¢brils
detected are unbranched, straight or slightly curved, and have
diameters of 5^10 nm. They are of variable length and show
no twisting pattern along the ¢bre axis. The decrease in in-
tensity of the CD spectrum observed after 2 days of incuba-
tion can therefore be associated with the formation of ¢brillar
species too large to give rise to signi¢cant CD absorption.
Fig. 1C shows electron micrographs of the sample taken
after a very prolonged period (24 weeks) of incubation at
pH 4 and room temperature. This micrograph reveals the
emergence of a dense network of ¢brils. The ¢brils are long,
unbranched and have a diameter of ca. 5^10 nm. Although
the sample shows a high degree of homogeneity in the mor-
phologies of the ¢brils some variations can be observed in
their appearance. In particular, two types of assemblies are
evident. The most common ¢brils have a smooth non-twisted
appearance, similar to those observed after just 2 days of
incubation while the others are twisted but with no well-de-
¢ned helical periodicity. These ¢brils appear to be the result of
the association of two or more distinct strands or proto¢la-
ments, a situation commonly observed in mature amyloid
¢brils [21^23]. The CD spectrum corresponding to the 24
week sample of SCR3(18^34) is also shown in Fig. 1A and
reveals a dominance of bands characteristic of L-sheet struc-
ture with a minimum at 216 nm and a positive band at ca. 237
nm. This result suggests that conversion of soluble SCR3(18^
Fig. 1. CD spectra (A) of a 50 WM solution of the SCR3(18^34)
peptide freshly dissolved in aqueous solution at pH 4 and room
temperature (dashed line), and after 2 days (dotted line), and 24
weeks (solid line) of incubation at room temperature. Electron mi-
crographs SCR3(18^34) ¢brils after 2 days (B) and 24 weeks (C) of
incubation at room temperature. Bars = 200 nm.
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34) to amyloid ¢brils is accompanied by a transition from a
random coil to L-sheet structure and that the ¢brils observed
are rich in L-sheet structure.
3.2. SDS as a promoter of ¢bril formation
CD spectra of SCR3(18^34) recorded in the presence of a
sub-micellar (3 mM) concentration of SDS are shown in Fig.
2A. The spectrum of the peptide recorded immediately after
dissolution in SDS is dramatically di¡erent from that ob-
served for the peptide in aqueous solution alone. The spectra
show a positive peak at 190 nm and two minima located at ca.
203 nm and 216 nm. The positions and their relative inten-
sities suggest that the peptide has acquired a substantial de-
gree of helical structure. The positions of the peaks are, how-
ever, shifted from those typical of K-helical conformations by
V5 nm; it is possible that this shift is indicative of distortions
to the regular helical structure, but could also be the result of
light scattering from some aggregated material [24].
The CD spectrum recorded after 30 min is, however, sig-
ni¢cantly changed from that described above; the peak at 203
nm is of lower intensity and there is an increased intensity of
the spectral component at 216 nm. The CD spectra collected
over 2 days show a transition to a curve typical of L-sheet
structure having a single minimum at 216 nm. The spectra
recorded for the ¢rst 340 min show a well-de¢ned isodichroic
point at 195.5 nm suggesting that the helical to sheet transi-
tion can, to a reasonable approximation, be described as a
two-state process. The species giving rise to the signals char-
acteristic of L-sheet structure are likely to be due to the pres-
ence of small aggregates because the formation of large ag-
gregates, as discussed above, leads to a loss of spectral
intensity from scattering e¡ects. The samples of SCR3(18^
34) incubated in the presence of sub-micellar SDS were also
analysed by EM (Fig. 2C). The results reveal the formation of
a large quantity of ¢brillar structures. Relative to those
formed in the absence of SDS, the ¢brils are very short but
have a much larger diameter (13^32 nm).
Fig. 2B shows the CD spectrum of SCR3(18^34) in the
presence of a higher concentration (20 mM) of SDS such
that it forms micelles. The spectrum is highly characteristic
of an K-helical conformation, with two minima at ca. 205 nm
and 222 nm and a positive band at ca. 190 nm. The spectrum
at room temperature was found to remain e¡ectively un-
changed over periods of time in excess of 2 days. Under these
conditions, therefore, the peptide appears to form a stable
K-helical structure that does not convert into amyloid ¢brils
over the time scale investigated here.
4. Discussion
The results described in this paper show that SCR3(18^34)
can be added to the increasingly long list of peptide and
proteins that have been shown to form well-de¢ned ¢brillar
aggregates under particular solution conditions. It adds to the
evidence that the ability to form amyloid ¢brils is a common
or generic property of polypeptide chains, dominated by the
interactions of the main chain that is common to all sequences
[5]. The CD data indicate that in aqueous solution the peptide
adopts a conformation without discernible non-random struc-
ture. The aggregation process under the conditions explored
here is very slow, but leads to the formation of a large number
of long, well-de¢ned ¢brils. The structure of the ¢brils is typ-
Fig. 2. A: Time evolution of the CD spectra of a 50 WM SCR3(18^
34) peptide solution in the presence of 3 mM SDS at pH 4 and
25‡C: 0 min (solid line); 30 min (dashed line), 70 min (dotted line),
180 min (dot^dashed line), 340 min (dot^dot^dashed line) and
2 days (dashed line). B: CD spectra of SCR3(18^34) in the presence
of 20 mM SDS at pH 4 and 25‡C freshly dissolved (solid line) and
after 2 days (dashed line) of incubation at room temperature.
C: Electron micrograph of 50 WM of SCR3(18^34) in the presence
of 3 mM SDS at pH 4, after 2 days of incubation at room tempera-
ture. Bar= 200 nm.
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ical of those produced by other peptides as a result of slow
growth in the absence of denaturant or co-solvent [21^23]. In
these cases, it has been suggested that the observed twisting of
the ¢brils is a consequence of the greater overall stability
resulting from factors such as the burial of exposed hydro-
phobic surfaces and an increase in van der Waals interactions
[22,25].
In the presence of sub-micellar concentrations of the deter-
gent SDS the peptide initially adopts a well-de¢ned helical
structure. After a short time, however, the CD spectrum
changes to one characteristic of L-structure and a large num-
ber of ¢brillar species are visible in the electron micrographs.
These ¢brils are much shorter and thicker than those formed
by slow growth in aqueous solution. The development of
L-structure over time is highly indicative of the formation of
aggregates and has frequently been observed for peptide frag-
ments [26]. The altered appearance of the SCR3(18^34) ¢brils
in SDS relative to those formed in pure water may be a result
either of the rapid growth of the ¢brils or a result of the
presence of SDS. It is well established that the morphology
of the assembly of amyloid proto¢laments into mature ¢brils
is highly dependent on solution conditions, primarily because
these conditions are likely to modulate the relatively weak
interactions between the highly stable component proto¢la-
ments [25]. It is also possible that SDS is incorporated in
some way into the structures, perhaps binding to the proto-
¢laments prior to their assembly.
Low concentrations of SDS promote rapid ¢bril formation
despite the fact that the initially formed, presumably mono-
meric, species are helical. A similar conversion of a soluble
K-helical non-globular state to L-rich aggregates has previ-
ously been observed for the protein acylphosphatase in mod-
erate concentrations of TFE, although at high concentrations
aggregation is strongly inhibited [7]. In the presence of TFE,
¢bril formation may be stimulated not just by unfolding but
by an enhanced stability of hydrogen bonding interactions. In
the case of SDS, it is likely that the alkyl chains of SDS
stimulate aggregation, perhaps by association with the peptide
molecules. Once such aggregates are formed, intermolecular
L-sheet interactions are likely to develop readily. Moreover, it
has been shown that even proteins such as myoglobin and
cytochrome c552, that have sequences with high propensities
for helical structure can form amyloid ¢brils under appropri-
ate conditions [9,10]. It is clear, however, that promotion of
helical structure in the absence of any other factors is likely to
inhibit aggregation by increasing the population of species
that form intramolecular hydrogen bonds, and hence reducing
the propensity to form intermolecular interactions [13,14]. In
this context it is interesting that in the presence of higher
concentrations of SDS, in which micelles are formed, ¢bril
formation is not observed for the SCR3(18^34) peptide.
Under these conditions the peptide again forms a helical
structure initially but the helical structure still remains over
long periods of time.
The ability of SDS both to promote ¢bril formation and to
inhibit it, depending on conditions, is particularly interesting
in the light of suggestions that interactions with membranes
and membrane components may be signi¢cant in in£uencing
aggregation and amyloid ¢bril formation in vivo [27]. For
example, interactions between the amyloid L-peptide and lipid
molecules have been suggested as playing an important role in
the pathogenesis of Alzheimer’s disease [28]. In addition, a
partially folded form of human K-lactalbumin interacting
with a lipid cofactor has been found to induce apoptosis in
tumour cells suggesting that the toxicity of non-native protein
species can be dramatically in£uenced by lipid binding [29].
Overall the ¢nding in this work that SDS can both stimulate
and inhibit ¢bril formation re£ects the sensitivity of this pro-
cess to the solution environment, a factor that is undoubtedly
a major aspect of the deposition and hence the toxicity of
¢brils in biological systems [30].
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